Markus Kleih

471 total citations
6 papers, 340 citations indexed

About

Markus Kleih is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Markus Kleih has authored 6 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Cancer Research. Recurrent topics in Markus Kleih's work include Lymphoma Diagnosis and Treatment (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Markus Kleih is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Markus Kleih collaborates with scholars based in Germany, Spain and Australia. Markus Kleih's co-authors include Walter E. Aulitzky, Simon Heine, Kathrin Böpple, Meng Dong, Monilola A. Olayioye, Frank Eßmann, Andrea Gaißler, Dolors Colomer, German Ott and Heiko van der Kuip and has published in prestigious journals such as Blood, Cancer Research and British Journal of Haematology.

In The Last Decade

Markus Kleih

6 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Kleih Germany 3 198 87 66 54 37 6 340
Andrea Gaißler Germany 4 182 0.9× 88 1.0× 64 1.0× 42 0.8× 35 0.9× 5 323
Myron K. Evans United States 7 228 1.2× 106 1.2× 68 1.0× 55 1.0× 48 1.3× 12 425
Zdeněk Škrott Czechia 10 169 0.9× 103 1.2× 57 0.9× 43 0.8× 45 1.2× 15 360
Lorenzo Colarossi Italy 13 211 1.1× 124 1.4× 103 1.6× 50 0.9× 44 1.2× 30 443
Jennifer L. Allensworth United States 7 281 1.4× 132 1.5× 82 1.2× 53 1.0× 44 1.2× 7 493
Tiantao Gao China 12 297 1.5× 96 1.1× 48 0.7× 36 0.7× 35 0.9× 18 460
Perry Dhaliwal India 2 251 1.3× 99 1.1× 66 1.0× 26 0.5× 39 1.1× 3 393
Tianxiu Dong China 12 211 1.1× 96 1.1× 103 1.6× 45 0.8× 36 1.0× 19 373
Federica Baldan Italy 14 364 1.8× 118 1.4× 105 1.6× 34 0.6× 40 1.1× 46 621
Amy J. Aldrich United States 8 294 1.5× 150 1.7× 85 1.3× 56 1.0× 42 1.1× 8 503

Countries citing papers authored by Markus Kleih

Since Specialization
Citations

This map shows the geographic impact of Markus Kleih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kleih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kleih more than expected).

Fields of papers citing papers by Markus Kleih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kleih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kleih. The network helps show where Markus Kleih may publish in the future.

Co-authorship network of co-authors of Markus Kleih

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Kleih. A scholar is included among the top collaborators of Markus Kleih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Kleih. Markus Kleih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Kleih, Markus, Kathrin Böpple, Meng Dong, et al.. (2019). Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death and Disease. 10(11). 851–851. 299 indexed citations
2.
Heine, Simon, Markus Kleih, Kathrin Böpple, et al.. (2018). Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA. Journal of Hematology & Oncology. 11(1). 112–112. 26 indexed citations
4.
Heine, Simon, Michael A. Dengler, Markus Kleih, et al.. (2017). Cyclin D1 Driven CDK4 Activity Is Responsible for Hypersensitivity to NOXA Inducing Combination Treatment in Mantle Cell Lymphoma (MCL) Cells. Blood. 130. 2811–2811. 1 indexed citations
5.
Montraveta, Arnau, Simon Heine, Markus Kleih, et al.. (2017). Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma. British Journal of Haematology. 177(4). 557–561. 12 indexed citations
6.
Ott, German, et al.. (2015). Dual Targeting of NOXA/MCL-1 Synergistically Induces Cell Death in Mantle Cell Lymphoma (MCL) Cells. Blood. 126(23). 2757–2757. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026